> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection Extension for Biosimilar User Fees
- URL: https://www.fdaweb.com/info-collection-extension-for-biosimilar-user-fees/
- Published: 2018-11-05T12:00:00.000Z
- Updated: 2026-09-15T00:42:30.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142741

*Federal Register* notice: FDA has submitted to OMB an information collection extension for “Biosimilars User Fee Program” (OMB Control Number 0910-0718). The Biosimilar User Fee Act of 2012 authorized FDA to assess and collect user fees for certain activities in connection with biosimilar biological product development. It was reauthorized for an additional five years in 8/2017\. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-11-05/pdf/2018-24130.pdf?ref=fdaweb.com).